All News

2018

January

Media Release / Jan 24, 2018

Novartis delivered good operational performance and landmark innovation in 2017, entering our next growth phase

Read More
Media Release / Jan 18, 2018

Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars

Read More
Media Release / Jan 16, 2018

Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA

Read More
2017

December

Media Release / Dec 08, 2017

Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine

Read More

November

Media Release / Nov 15, 2017

Sandoz Scientific Standalone Event in Russia “Combat Infections to Save Lives”

Read More
Media Release / Nov 14, 2017

New data reinforces clinical basis for switching to Sandoz biosimilar medicines

Read More

October

Media Release / Oct 27, 2017

Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Read More
Media Release / Oct 24, 2017

Novartis delivered growth on top and bottom line in all divisions in Q3

Read More

September

Media Release / Sep 14, 2017

Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study

Read More
Media Release / Sep 12, 2017

Sandoz proposed biosimilar rituximab accepted for review by the FDA

Read More

Pages